-
Find us easily on Google MapsFind us easily on Google Maps
-
info@oncolinkpharmacy.cominfo@oncolinkpharmacy.com
-
Contact Us +92 327 6170609Contact Us +92 327 6170609

Generic Name: Bevacizumab
Brand Category: Monoclonal Antibody / Targeted Therapy
Dosage Form: Injection for Intravenous Infusion
Category: Anti-Cancer Medicine
Availability: Available at OncoLink Pharmacy with Nationwide Delivery Across Pakistan
Bevacizumab is a targeted cancer therapy known as a monoclonal antibody. It works by blocking a protein called vascular endothelial growth factor (VEGF), which helps tumors develop new blood vessels. By inhibiting the formation of these blood vessels, Bevacizumab reduces the blood supply that tumors need for growth and spread.
Unlike traditional chemotherapy, which directly attacks rapidly dividing cells, Bevacizumab targets specific biological pathways involved in cancer progression. This targeted approach allows it to be used alongside chemotherapy and other cancer treatments in selected patients.
Bevacizumab is widely used in modern oncology and has become an important treatment option for several advanced and metastatic cancers.
Doctors may prescribe Bevacizumab as part of a comprehensive cancer treatment plan for various types of cancer, including:
Bevacizumab is commonly used in combination with chemotherapy for advanced or metastatic colorectal cancer. It helps slow tumor growth and may improve treatment outcomes in eligible patients.
In certain patients with advanced non-squamous non-small cell lung cancer, Bevacizumab may be combined with chemotherapy to support disease management.
Bevacizumab may be used in selected ovarian cancer treatment protocols, particularly in advanced or recurrent disease.
Patients with persistent, recurrent, or metastatic cervical cancer may receive Bevacizumab in combination with other anti-cancer medications.
Bevacizumab is also used in some cases of recurrent glioblastoma, an aggressive type of brain tumor. Treatment decisions should always be made by a qualified oncologist based on the patient’s diagnosis, disease stage, overall health, and treatment history.
Cancer cells require a continuous blood supply to obtain oxygen and nutrients. To achieve this, tumors release signals that stimulate the growth of new blood vessels.
Bevacizumab targets VEGF, a key protein responsible for angiogenesis (the formation of new blood vessels). By blocking VEGF, the medicine:
This mechanism has made Bevacizumab one of the most widely used targeted therapies in oncology.
Bevacizumab is administered as an intravenous (IV) infusion under the supervision of trained healthcare professionals. The dosage and treatment schedule depend on factors such as:
Patients should never attempt to self-administer Bevacizumab. Treatment should only be provided in a hospital, oncology center, or healthcare facility equipped to manage infusion therapies.
Like all cancer medicines, Bevacizumab can cause side effects. Not every patient experiences the same reactions, and many side effects can be managed with appropriate medical care. Common side effects may include:
Serious side effects may occur in some patients and require immediate medical attention. Patients should promptly inform their healthcare team about any unusual symptoms experienced during treatment.
Before starting Bevacizumab treatment, patients should discuss their complete medical history with their oncologist. Special precautions may be required for patients who have:
Pregnant or breastfeeding women should consult their healthcare provider regarding the risks associated with treatment. This medicine should only be used under the supervision of qualified healthcare professionals.
Bevacizumab should be stored according to the manufacturer’s recommendations. General storage guidelines include:
Hospitals and pharmacies should follow approved storage protocols to maintain product quality and effectiveness.
The price of Bevacizumab in Pakistan varies depending on the brand, strength, vial size, manufacturer, and current market availability. As a specialized oncology medicine, Bevacizumab is available in multiple strengths and may be prescribed as part of a targeted treatment plan for various cancers. For the latest price, stock availability, and delivery information, patients and healthcare providers can contact OncoLink Pharmacy directly.
At OncoLink Pharmacy, we strive to provide authentic oncology medicines sourced from trusted pharmaceutical manufacturers while ensuring reliable nationwide delivery across Pakistan.
OncoLink Pharmacy is committed to helping patients access genuine oncology medicines with confidence.
We source products from trusted pharmaceutical manufacturers and authorized distribution channels.
We deliver specialty medicines across Pakistan, including Lahore, Karachi, Islamabad, Rawalpindi, Faisalabad, Multan, Peshawar, and other cities.
Our team understands the unique requirements of cancer patients and healthcare providers.
We help patients and institutions access difficult-to-source oncology medicines whenever possible.
Our representatives can provide information regarding availability, product specifications, and ordering procedures.
If you are looking for Bevacizumab in Pakistan, OncoLink Pharmacy can assist with product availability and nationwide delivery. Contact our team today for the latest price information, stock status, and ordering support.
There are no reviews yet.